Diabexy

Dr. Arun Gupta, founder of Diabexy, is an endocrinologist with 15+ years diabetes management experience in clinical practice. His motivation: India has 77M+ diabetics but lacks integrated digital solutions for comprehensive management. Diabexy was created as comprehensive platform combining remote monitoring, AI-powered coaching, and community support for diabetes management at scale.

Diabexy is comprehensive digital diabetes management platform with mobile app, wearable integration, and telemedicine features. Platform allows users to track blood glucose, medications, diet, and exercise; receive AI-personalized recommendations; connect with certified diabetes educators; and access doctor consultations via video. Combines medical expertise with technology for holistic diabetes care accessible to millions.

Amount: Rs 1.5 crore | Equity: 6% | Valuation: Rs 25 crore

Dr. Gupta presented India's diabetes crisis: 77M+ diabetics with most undiagnosed or unmanaged. Digital management reduces complications and improves outcomes significantly. Metrics: 200,000+ users, 30,000+ active daily users, 15 lakh consultations completed, clinical partnerships with 200+ hospitals, 4.9/5 rating.

Namita Thapar strongly resonated with healthcare solution addressing serious health crisis. Her pharmaceutical industry background gave her credibility to evaluate medical claims independently. She appreciated clinical validation and hospital partnerships validating the model. Anupam Mittal was supportive but raised regulatory questions about telemedicine consultation model and data privacy.

Namita offered Rs 1.5 crore for 9% equity valuing company at Rs 16.6 crore. Dr. Gupta countered Rs 1.5 crore for 6% citing clinical partnerships, user scale, and regulatory approvals. Namita accepted 6%, valuing clinical credibility and Dr. Gupta's medical expertise. Deal included hospital network introductions and pharma distribution partnerships.

Deal Secured: YES | Investment: Rs 1.5 crore | Equity: 6% | Shark: Namita Thapar